China has blocked SoftBank's $5.4 billion acquisition of ABB robotics division, citing concerns over robotics data transfer and AI training. The decision by China's National Development and Reform Commission disrupts Masayoshi Son's physical AI strategy and raises questions about foreign investment security in China's critical technology sectors.

China has dealt a significant blow to SoftBank's artificial intelligence ambitions by blocking the Japanese firm's $5.4 billion acquisition of the ABB robotics division

1

. The decision by China's National Development and Reform Commission (NDRC) came as a shock to SoftBank, which had expected approval until last week

1

. The move highlights Beijing's growing concerns about data sovereignty and technological sovereignty in the AI era, particularly regarding the transfer of critical assets developed in China to foreign companies.

NDRC Cites Data Transfer and AI Training Concerns

The NDRC's decision to block the takeover centered on concerns about robotics data transfer overseas, where it could potentially be used for AI training purposes

2

. Chinese regulators were particularly worried about data being used to train AI models developed by OpenAI, in which SoftBank is a major investor

1

. The foreign investment security review included detailed scrutiny of ABB's Chinese supply chains and demands to retain manufacturing capabilities within China

1

. Regulators had examined keeping intellectual property relating to ABB's robotics business in China, potentially requiring parts of the business to be spun off to Chinese owners for the deal to proceed

1

.

ABB's Deep Roots in China's Robotics Market

China represents the biggest market for the ABB robotics division, with more than 90 per cent of its robots for Chinese customers manufactured locally

1

. The Swiss-Swedish company employs approximately 12,700 people in China and has benefited from long-standing government support since establishing a joint venture with a Chinese partner in 1992

1

. Shanghai's government helped ABB build its $150 million robotics mega-factory in Pudong Shanghai, which began operating in 2022

1

. China's robotics market represents around 30 per cent of ABB's total robots business

2

, making the Chinese operations a significant attraction for SoftBank's deal

1

.

Impact on Masayoshi Son's Physical AI Strategy

For Masayoshi Son, the blocked acquisition represents a major setback to his physical AI strategy. SoftBank agreed to the deal last October as part of its push into a sector it believes will be tied to the rise of AI

1

. The ABB robotics division was intended to form the basis of Son's plans in the sector alongside AI and robotics company Roze in the US

1

. Son is also in talks to buy Allied Universal, the world's largest private security group, with plans to use robotics and AI to increase productivity

1

. Bloomberg Intelligence analyst Kirk Boodry noted that while ABB Robotics lacks cutting-edge innovation found across SoftBank's physical AI startup portfolio, its domain expertise and manufacturing knowhow had been expected to transform robotic concepts into actual businesses

3

.

Source: Japan Times

Source: Japan Times

Market Reaction and Broader Implications

SoftBank shares fell approximately 7 per cent in Tokyo following the announcement

3

. The company's stock has already declined 38 per cent in the past month and 28 per cent over the past year amid concerns about AI demand and OpenAI's decision to push its IPO into next year

1

. That delay has also put pressure on SoftBank's looming listing of its US data centre developer SB Energy, which is targeting a $50 billion valuation

1

. The decision reflects Beijing's renewed emphasis on safeguarding supply chain security and stability in the AI era

3

. In April, China similarly blocked Meta Platforms's $2 billion acquisition of agentic AI startup Manus, issuing a brief notice prohibiting foreign investment in accordance with laws and regulations

3

. Watch for how SoftBank responds to this setback and whether it attempts to restructure the deal to address Chinese regulatory concerns, as the company is now trying to determine what went wrong and whether it could seek approval again

1

.

Today's Top Stories

© 2026 TheOutpost.AI All rights reserved